| Predicate |
Object |
| contentType |
Journal Article|Comment |
| endingPage |
60 |
| issn |
2374-2437 |
| issueIdentifier |
1 |
| pageRange |
59-60 |
| publicationName |
JAMA Oncology |
| startingPage |
59 |
| bibliographicCitation |
Lin DW, Nelson PS. Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence? JAMA Oncol. 2021 Jan 01;7(1):59–60. doi: 10.1001/jamaoncol.2020.6045. PMID: 33237305. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8503e1fbf599dd58d01d42e396fa2f7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f |
| date |
2021-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/33237305
https://doi.org/10.1001/jamaoncol.2020.6045 |
| isPartOf |
https://portal.issn.org/resource/ISSN/2374-2437
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43608 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Prognostic Genomic Biomarkers in Patients With Localized Prostate Cancer: Is Rising Utilization Justified by Evidence? |
| discusses |
http://id.nlm.nih.gov/mesh/M0026444 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D011471Q000235 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D023281
http://id.nlm.nih.gov/mesh/D017430
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D011379 |